North America Bioinformatics Market Size, Share & Industry Trends Analysis Report By Product & Services (Knowledge Management Tools, Bioinformatics Platforms and Bioinformatics Services), By Sector, By Application, By Country and Growth Forecast, 2022 - 2028
The North America Bioinformatics Market would witness market growth of 11.4% CAGR during the forecast period (2022-2028).
Increased demand for protein and nucleic acid sequencing, increased government and commercial sector activities, the rapid advancement of proteomics and genomics, and increased study of molecular biology and drug development are all contributing reasons to the growth of the bioinformatics industry. The field of bioinformatics is expanding in significance as massive volumes of data generated by methods such as protein and nucleic acid sequencing need to be interpreted and managed for use in medicine and future research.
The introduction of technologically advanced bioinformatics software like BALL, Bioclipse, RasMol, and AUTODOCK, as well as rising market adoption of such tools for accurate and effective analysis of biomarkers discovery programs that support in toxicity detection throughout the initial stage of the drug development process, are also anticipated to boost industry growth over the next few years. For instance, My Intelligent Machines (MIMs) introduced potent software for cancer medication development in June 2022.
The need for meta-analysis of microarray data, computational epigenetics, differentially expressed genes, gene networks, systems biology needs, and gene-associating research, among other things, have also significantly impacted the expansion of the bioinformatics market.
The US contributes the largest revenue share in the North America market. The market expansion is linked to rising pharmaceutical and biopharmaceutical firms, rising healthcare and research spending, and rising government support for advancing academic and research institutions. The US Centers for Medicare & Medicaid Services estimate that national healthcare spending in the US will exceed US$ 4.1 trillion in 2020, up 9.7% from 2019.
The US market dominated the North America Bioinformatics Market by Country in 2021; thereby, achieving a market value of $6.0 Billion by 2028. The Canada market is poised to grow at a CAGR of 14% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 12.9% during (2022 - 2028).
Based on Product & Services, the market is segmented into Knowledge Management Tools, Bioinformatics Platforms and Bioinformatics Services. Based on Sector, the market is segmented into Medical Biotechnology, Plant Biotechnology, Environmental Biotechnology, Animal Biotechnology, Forensic Biotechnology and Others. Based on Application, the market is segmented into Genomics, Chemoinformatics & Drug Design, Transcriptomics, Metabolomics, Proteomics and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Qiagen N.V., Agilent Technologies, Inc., Illumina, Inc., Waters Corporation, PerkinElmer Inc., Genedata AG, Neogenomics laboratories, BGI Group
Scope of the Study
Market Segments covered in the Report:
By Product & Services
- Knowledge Management Tools
- Bioinformatics Platforms
- Bioinformatics Services
- Medical Biotechnology
- Plant Biotechnology
- Environmental Biotechnology
- Animal Biotechnology
- Forensic Biotechnology
- Others
- Genomics
- Chemoinformatics & Drug Design
- Transcriptomics
- Metabolomics
- Proteomics
- Others
- US
- Canada
- Mexico
- Rest of North America
- Thermo Fisher Scientific, Inc.
- Eurofins Scientific SE
- Qiagen N.V.
- Agilent Technologies, Inc.
- Illumina, Inc.
- Waters Corporation
- PerkinElmer Inc.
- Genedata AG
- Neogenomics laboratories
- BGI Group
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Bioinformatics Market, by Product & Services
- 1.4.2 North America Bioinformatics Market, by Sector
- 1.4.3 North America Bioinformatics Market, by Application
- 1.4.4 North America Bioinformatics Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
- Chapter 3. Competition Analysis - Global
- 3.1 KBV Cardinal Matrix
- 3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
- 3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Jun – 2022, Oct) Leading Players
- Chapter 4. North America Bioinformatics Market by Product & Services
- 4.1 North America Knowledge Management Tools Market by Country
- 4.2 North America Bioinformatics Platforms Market by Country
- 4.3 North America Bioinformatics Services Market by Country
- Chapter 5. North America Bioinformatics Market by Sector
- 5.1 North America Medical Biotechnology Market by Country
- 5.2 North America Plant Biotechnology Market by Country
- 5.3 North America Environmental Biotechnology Market by Country
- 5.4 North America Animal Biotechnology Market by Country
- 5.5 North America Forensic Biotechnology Market by Country
- 5.6 North America Others Market by Country
- Chapter 6. North America Bioinformatics Market by Application
- 6.1 North America Genomics Market by Country
- 6.2 North America Chemoinformatics & Drug Design Market by Country
- 6.3 North America Transcriptomics Market by Country
- 6.4 North America Metabolomics Market by Country
- 6.5 North America Proteomics Market by Country
- 6.6 North America Others Market by Country
- Chapter 7. North America Bioinformatics Market by Country
- 7.1 US Bioinformatics Market
- 7.1.1 US Bioinformatics Market by Product & Services
- 7.1.2 US Bioinformatics Market by Sector
- 7.1.3 US Bioinformatics Market by Application
- 7.2 Canada Bioinformatics Market
- 7.2.1 Canada Bioinformatics Market by Product & Services
- 7.2.2 Canada Bioinformatics Market by Sector
- 7.2.3 Canada Bioinformatics Market by Application
- 7.3 Mexico Bioinformatics Market
- 7.3.1 Mexico Bioinformatics Market by Product & Services
- 7.3.2 Mexico Bioinformatics Market by Sector
- 7.3.3 Mexico Bioinformatics Market by Application
- 7.4 Rest of North America Bioinformatics Market
- 7.4.1 Rest of North America Bioinformatics Market by Product & Services
- 7.4.2 Rest of North America Bioinformatics Market by Sector
- 7.4.3 Rest of North America Bioinformatics Market by Application
- Chapter 8. Company Profiles
- 8.1 Thermo Fisher Scientific, Inc.
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 Recent strategies and developments:
- 8.1.5.1 Partnerships, Collaborations, and Agreements:
- 8.2 Eurofins Scientific SE
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Regional Analysis
- 8.2.4 Recent strategies and developments:
- 8.2.4.1 Acquisition and Mergers:
- 8.3 Qiagen N.V.
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Regional Analysis
- 8.3.4 Research & Development Expense
- 8.3.5 Recent strategies and developments:
- 8.3.5.1 Product Launches and Product Expansions:
- 8.3.5.2 Acquisition and Mergers:
- 8.4 Agilent Technologies, Inc.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Segmental and Regional Analysis
- 8.4.4 Research & Development Expense
- 8.4.5 Recent strategies and developments:
- 8.4.5.1 Partnerships, Collaborations, and Agreements:
- 8.4.5.2 Acquisition and Mergers:
- 8.5 Illumina, Inc.
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Regional Analysis
- 8.5.4 Research & Development Expense
- 8.5.5 Recent strategies and developments:
- 8.5.5.1 Partnerships, Collaborations, and Agreements:
- 8.5.5.2 Product Launches and Product Expansions:
- 8.5.5.3 Acquisition and Mergers:
- 8.6 PerkinElmer, Inc.
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Segmental and Regional Analysis
- 8.6.4 Research & Development Expense
- 8.6.5 Recent strategies and developments:
- 8.6.5.1 Partnerships, Collaborations, and Agreements:
- 8.6.5.2 Product Launches and Product Expansions:
- 8.7 Waters Corporation
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental and Regional Analysis
- 8.7.4 Research & Development Expense
- 8.7.5 Recent strategies and developments:
- 8.7.5.1 Partnerships, Collaborations, and Agreements:
- 8.8 Neogenomics, Inc.
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Segmental Analysis
- 8.8.4 Research & Development Expenses
- 8.8.5 Recent strategies and developments:
- 8.8.5.1 Partnerships, Collaborations, and Agreements:
- 8.9 BGI Group
- 8.9.1 Company Overview
- 8.9.2 Recent strategies and developments:
- 8.9.2.1 Partnerships, Collaborations, and Agreements:
- 8.10. Genedata AG
- 8.10.1 Company Overview
- 8.10.2 Recent strategies and developments:
- 8.10.2.1 Partnerships, Collaborations, and Agreements:
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook